Biostem Technologies Inc
OTC:BSEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Paragon Union Bhd
KLSE:PGLOBE
|
MY |
|
Online Vacation Center Holdings Corp
OTC:ONVC
|
US |
|
A
|
ActBlue Co Ltd
SZSE:300816
|
CN |
|
A
|
Alliance Global Group Inc
XPHS:AGI
|
PH |
|
E
|
Earlyworks Co Ltd
NASDAQ:ELWS
|
JP |
|
A
|
Aquarius AI Inc
CNSX:AQUA
|
CA |
|
P
|
Pioneer Embroideries Ltd
NSE:PIONEEREMB
|
IN |
Biostem Technologies Inc
Inventory
Biostem Technologies Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biostem Technologies Inc
OTC:BSEM
|
Inventory
$2.9m
|
CAGR 3-Years
108%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Inventory
$14.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Inventory
$2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Pfizer Inc
NYSE:PFE
|
Inventory
$10.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Inventory
$6.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Inventory
$13.7B
|
CAGR 3-Years
47%
|
CAGR 5-Years
28%
|
CAGR 10-Years
15%
|
|
Biostem Technologies Inc
Glance View
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2001-07-11. The firm is focused on harnessing elements of perinatal tissue and the body’s innate biology to repair or reverse damage caused by a range of degenerative diseases. Its approach, called Local MicroEnvironment Activation (LMA) platform uses combinations of small molecules, cytokines, and growth factors to activate the microenvironment within the body to create communication for repair in the tissue. Its products include RHEO, OROPRO, AEON, VENDAJE, VENDAJE AC, VENDAJE OPTIC, PROVISCUS, NEOFYL and ONIX. Its RHEO is a cushioning agent for homologous supplementation, which is derived from human amniotic tissue. Its OROPRO is derived from human umbilical cord and is a Wharton's jelly tissue allograft. Its VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. The VENDAJE AC is a structural tissue allograft composed of the amnion and chorion layer of the placental membrane.
See Also
What is Biostem Technologies Inc's Inventory?
Inventory
2.9m
USD
Based on the financial report for Dec 31, 2025, Biostem Technologies Inc's Inventory amounts to 2.9m USD.
What is Biostem Technologies Inc's Inventory growth rate?
Inventory CAGR 3Y
108%
Over the last year, the Inventory growth was 58%. The average annual Inventory growth rates for Biostem Technologies Inc have been 108% over the past three years .
